On February 11, Capital State learned that Stelry Medical (code: STE.US), a listed company in the United States, released its third quarter report for fiscal 2022.
From April 1, 2021 to December 31, 2021, the company's operating income was $3.374 billion, an increase of 51.05% year-on-year, and net profit attributable to the parent company was $192 million, down 38.18% year-on-year, and basic earnings per share were $1.98.
The company's industry is life science tools and services.
Revenue from health care was $2,107 million, applied sterilization technology was $630 million, life sciences was $382 million, dental revenue was $256 million, and corporate and other revenue was $0.0000.
This article originated from Capital State
![On December 16, Terry Machine traded 1.39 million shares at 8.60 yuan per share, at a discount of 11.43%[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)